Search Results

There are 10232 results for: content related to: An observational, prospective study of monthly adalimumab therapy for disease maintenance in psoriasis patients: a possible new therapeutic option for good responders to the initial induction treatment

  1. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 658–667, C. Leonardi, J.M. Sobell, J.J. Crowley, U. Mrowietz, Y. Bao, P.M. Mulani, Y. Gu and M.M. Okun

    Article first published online : 20 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11041.x

  2. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

    British Journal of Dermatology

    Volume 163, Issue 4, October 2010, Pages: 838–846, P.P.M. Van Lümig, L.L.A. Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof and E.M.G.J. De Jong

    Article first published online : 22 JUL 2010, DOI: 10.1111/j.1365-2133.2010.09950.x

  3. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis

    British Journal of Dermatology

    Volume 167, Issue s3, November 2012, Pages: 12–20, J. Leman and A.D. Burden

    Article first published online : 22 OCT 2012, DOI: 10.1111/j.1365-2133.2012.11209.x

  4. You have free access to this content
    Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

    The Journal of Dermatology

    Volume 37, Issue 4, April 2010, Pages: 299–310, Akihiko ASAHINA, Hidemi NAKAGAWA, Takafumi ETOH, Mamitaro OHTSUKI and THE ADALIMUMAB M04-688 STUDY GROUP

    Article first published online : 26 FEB 2010, DOI: 10.1111/j.1346-8138.2009.00748.x

  5. Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 5, May 2013, Pages: 593–600, P.P.M. van Lümig, P.C.M. van de Kerkhof, J.B.M. Boezeman, R.J.B. Driessen and E.M.G.J. de Jong

    Article first published online : 15 MAR 2012, DOI: 10.1111/j.1468-3083.2012.04496.x

  6. Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 9, November 2014, Pages: 1044–1055, C. Ma, V. Huang, D. K. Fedorak, K. I. Kroeker, L. A. Dieleman, B. P. Halloran and R. N. Fedorak

    Article first published online : 3 SEP 2014, DOI: 10.1111/apt.12940

  7. You have free access to this content
    Treatment effect of adalimumab and infliximab in Japanese psoriasis patients: Results in a single community-based hospital

    The Journal of Dermatology

    Volume 39, Issue 3, March 2012, Pages: 265–268, Shinji NODA, Kyoko MIZUNO and Makoto ADACHI

    Article first published online : 29 NOV 2011, DOI: 10.1111/j.1346-8138.2011.01312.x

  8. You have free access to this content
    Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1296–1309, R. PANACCIONE, J.-F. COLOMBEL, W. J. SANDBORN, P. RUTGEERTS, G. R. D’HAENS, A. M. ROBINSON, J. CHAO, P. M. MULANI and P. F. POLLACK

    Article first published online : 18 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04304.x

  9. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 9, September 2011, Pages: 1012–1020, J.-P. Ortonne, S. Chimenti, K. Reich, R. Gniadecki, P. Sprøgel, K. Unnebrink, H. Kupper, O. Goldblum and D. Thaçi

    Article first published online : 9 JAN 2011, DOI: 10.1111/j.1468-3083.2010.03944.x

  10. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Article first published online : 11 OCT 2012, DOI: 10.1002/art.37735

  11. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  12. Adalimumab (Humira)

    Handbook of Therapeutic Antibodies

    Hartmut Kupper, Jochen Salfeld, Daniel Tracey, Joachim R. Kalden, Pages: 696–732, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch27

  13. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab

    Journal of the European Academy of Dermatology and Venereology

    R. Bissonnette, C. Maari, K. Barber, C.W. Lynde and R. Vender

    Article first published online : 20 JAN 2015, DOI: 10.1111/jdv.12943

  14. Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 818–825, David T. Rubin, Parvez Mulani, Jingdong Chao, Paul F. Pollack, Arielle G. Bensimon, Andrew P. Yu and Subrata Ghosh

    Article first published online : 1 SEP 2011, DOI: 10.1002/ibd.21836

  15. The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 8, August 2012, Pages: 991–998, H.-Y. Chiu, T.-S. Wang, C.-Y. Chang and T.-F. Tsai

    Article first published online : 4 AUG 2011, DOI: 10.1111/j.1468-3083.2011.04199.x

  16. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics

    Journal of the European Academy of Dermatology and Venereology

    P. Sator, L. Richter, W. Saxinger, M. Vasiljevic and G. Stingl

    Article first published online : 9 FEB 2015, DOI: 10.1111/jdv.12981

  17. Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

    British Journal of Clinical Pharmacology

    Volume 79, Issue 2, February 2015, Pages: 286–297, David Ternant, Emilie Ducourau, Piéra Fuzibet, Céline Vignault, Hervé Watier, Thierry Lequerré, Xavier Le Loët, Olivier Vittecoq, Philippe Goupille, Denis Mulleman and Gilles Paintaud

    Article first published online : 20 JAN 2015, DOI: 10.1111/bcp.12509

  18. You have full text access to this OnlineOpen article
    Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 767–776, K.B. Gordon, A.B. Gottlieb, R.G. Langely, P. van de Kerkhof, K.T. Belasco, M. Sundaram, M. Okun and L. Serra

    Article first published online : 3 OCT 2014, DOI: 10.1111/jdv.12677

  19. You have full text access to this OnlineOpen article
    Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 10, November 2013, Pages: 1236–1247, R. Panaccione, J.-F. Colombel, W. J. Sandborn, G. D'Haens, Q. Zhou, P. F. Pollack, R. B. Thakkar and A. M. Robinson

    Article first published online : 22 SEP 2013, DOI: 10.1111/apt.12499

  20. Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 11-12, December 2014, Pages: 1324–1332, F. Baert, N. Vande Casteele, S. Tops, M. Noman, G. Van Assche, P. Rutgeerts, A. Gils, S. Vermeire and M. Ferrante

    Article first published online : 2 OCT 2014, DOI: 10.1111/apt.12968